Short-Chain Fatty Acids (SCFAs)

Acetate (C2)#

Most abundant SCFA in the colon (~60% of total); produced by many genera including Bifidobacterium, Bacteroides, Prevotella, and Ruminococcus via the Wood-Ljungdahl pathway or pyruvate decarboxylation.

Enters systemic circulation and is used as substrate by peripheral tissues and as a precursor for butyrate via cross-feeding.

Propionate (C3)#

Produced primarily via the succinate pathway by Bacteroides, Dialister, Veillonella, and Phascolarctobacterium; also via the acrylate and propanediol pathways by Akkermansia muciniphila and Roseburia inulinivorans.

Absorbed and largely cleared by the liver; regulates gluconeogenesis and cholesterol synthesis.

Butyrate (C4)#

The most biologically potent SCFA. Produced via butyryl-CoA:acetate CoA-transferase pathway by Faecalibacterium prausnitzii, Roseburia, Blautia, Eubacterium rectale, and Coprococcus. Primary energy source for colonocytes (~70% of their energy); maintains epithelial integrity.

Receptor Signaling#

GPR43 (FFAR2): Activated by acetate and propionate. Expressed on immune cells, enteroendocrine cells. Drives anti-inflammatory responses; stimulates GLP-1 and PYY secretion.

GPR41 (FFAR3): Activated by propionate and butyrate. Expressed on enteric neurons and sympathetic ganglia. Regulates gut motility, energy expenditure, and blood pressure via Olfr78 counter-regulation.^{[1]Emerging therapy targets to modulate microbiome-mediated effects evident in cardiovascular diseaseDorothea Katharina Hoffelner, Tim Hendrikx · 2025Open reference 1 ↓}

GPR109A (HCAR2): Activated by butyrate and niacin. Expressed on colonocytes, macrophages, dendritic cells. Promotes Treg differentiation and IL-10 production; suppresses NF-kB.

Gut Barrier Maintenance#

SCFAs—especially butyrate—are essential for intestinal barrier integrity. Provide 60-70% of colonocyte energy via beta-oxidation, maintaining the metabolic health of the epithelium. Stimulate mucin production by goblet cells.

Upregulate tight junction protein expression via HDAC inhibition and AMPK activation.

Maintain the hypoxic environment of the colonic crypt necessary for anaerobic commensal survival (see Hypoxic Signaling (HIF-1α Pathway)).

SCFAs in Neuroinflammation and the Gut-Brain Axis#

Butyrate modulates Neuroinflammation by reducing microglial activation and shifting microglia from pro-inflammatory M1 to anti-inflammatory M2 phenotype.^{[2]Sodium Butyrate Attenuates Microglia-Mediated Neuroinflammation by Modulating the TLR4/MyD88/NF-kB Pathway and Microbiome-Gut-Brain Axis in Cardiac Arrest MiceJianfei Sun, Liping Lu, Yingtao Lian et al. · 2025Open reference 2 ↓}

SCFAs signal to the brain via vagal afferents (GPR41/43 on enteric neurons) and via systemic circulation crossing the blood-brain barrier.^{[3]Mechanism of Iron Ion Homeostasis in Intestinal Immunity and Gut Microbiota RemodelingHonghong Bao, Yi Wang, Hanlin Xiong et al. · 2024Open reference 3 ↓}

Reduced fecal SCFAs documented in ASD, with altered profiles correlating with GI symptoms and behavioral severity.^{[4]He 2023 — Altered Gut Microbiota and Short-Chain Fatty Acids in Chinese Children with Constipated Autism Spectrum DisorderJianquan He, Xiuhua Gong, Bing Hu et al. · 2023Open reference 4 ↓[5]Liu 2019 — Altered Gut Microbiota and Short Chain Fatty Acids in Chinese Children with Autism Spectrum DisorderSimeng Liu, Enyao Li, Zhenyu Sun et al. · 2019Open reference 5 ↓}

SCFAs and Blood Pressure Regulation#

SCFAs regulate blood pressure through opposing receptor systems. GPR41: propionate binding causes vasodilation and BP reduction. Olfr78: propionate/acetate binding on renal juxtaglomerular cells stimulates renin release, raising BP.

Net effect depends on SCFA concentration and receptor balance; SCFA depletion from Dysbiosis generally associates with Hypertension.^{[1]Emerging therapy targets to modulate microbiome-mediated effects evident in cardiovascular diseaseDorothea Katharina Hoffelner, Tim Hendrikx · 2025Open reference 1 ↓}